The largest database of trusted experimental protocols

Simbiology v 4

Manufactured by MathWorks
Sourced in United States

Simbiology® v.4.3.1 is a software tool for modeling and simulating biological systems. It provides a framework for creating and analyzing dynamic models of biological processes, including signaling pathways, metabolic networks, and gene regulatory networks.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using simbiology v 4

1

Pediatric PBPK Modeling for Cabotegravir and Rilpivirine

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PBPK models were constructed using Simbiology® v.4.3.1, a product of Matlab® v.8.2 (MathWorks, Natick, MA, USA 2013). Instant and uniform distribution of drugs into tissues, no reabsorption of the drug from the large intestine and a blood-flow limited model [20 (link)] were assumed. A previously published adult IM PBPK model was used in this study [21 ]. Cabotegravir and rilpivirine LAI IM pharmacokinetics were simulated and validated in adult PBPK models and later optimised for different weight categories of children (3-12 years) and adolescents (12-18 years). Children and adolescents between the ages 3-18 years were divided into WHO weight groups [22 ] and 100 virtual individuals were generated in each weight category.
+ Open protocol
+ Expand
2

Physiologically-Based Pharmacokinetic Modeling of Key ARVs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Virtual patients between the ages of 18 to 60 years were generated. All organs and tissues were represented as individual compartments. The model was based on the assumptions: 1) well stirred compartments with instant distribution of the drug; 2) no absorption of the drug from the colon; and 3) the model is blood flow limited. The PBPK model was designed using Simbiology v.4.3.1, a product of Matlab v.8.2 (MathWorks, Natick, MA, USA 2013). The PBPK approach has been developed for key ARVs (two nucleoside reverse-transcriptase inhibitors (NRTIs), tenofovir and emtricitabine; three non-nucleoside reverse-transcriptase inhibitors (NNRTIs), efavirenz, rilpivirine and etravirine; two integrase inhibitors (IIs), raltegravir and dolutegravir and an unboosted protease inhibitor (PI), atazanavir.
+ Open protocol
+ Expand
3

Whole-Body PBPK Model for Intradermal Drug Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
A whole-body PBPK model was used to assess the intradermal release from MAPs in healthy adults. An intradermal compartment was appended to an earlier PBPK model using Simbiology® v.4.3.1., a product of MATLAB® v.8.2 (MathWorks, Natick, MA, USA 2013) (25 (link)) Drug distribution was described using blood flow-limited, first-order kinetics (26 (link)). Instant and uniform drug distribution across each tissue and organ was assumed. Ethical approval was not required for this study as the data was computer generated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!